157 related articles for article (PubMed ID: 36789562)
1. New established cell lines from undifferentiated pleomorphic sarcoma for in vivo study.
Lee EY; Kim YH; Rayhan MA; Kang HG; Kim JH; Park JW; Park SY; Lee SH; You HJ
BMB Rep; 2023 Apr; 56(4):258-264. PubMed ID: 36789562
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
Ono T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Akiyama T; Sugaya J; Fukushima S; Kojima N; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
[TBL] [Abstract][Full Text] [Related]
3. Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.
De Vita A; Recine F; Mercatali L; Miserocchi G; Spadazzi C; Liverani C; Bongiovanni A; Pieri F; Casadei R; Riva N; Fausti V; Amadori D; Ibrahim T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292724
[TBL] [Abstract][Full Text] [Related]
4. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
[TBL] [Abstract][Full Text] [Related]
5. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.
Bhalla AD; Landers SM; Singh AK; Landry JP; Yeagley MG; Myerson GSB; Delgado-Baez CB; Dunnand S; Nguyen T; Ma X; Bolshakov S; Menegaz BA; Lamhamedi-Cherradi SE; Mao X; Song X; Lazar AJ; McCutcheon IE; Slopis JM; Ludwig JA; Lev DC; Rai K; Torres KE
Lab Invest; 2022 Jun; 102(6):658-666. PubMed ID: 35228656
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor LBH589 inhibits undifferentiated pleomorphic sarcoma growth via downregulation of FOS-like antigen 1.
Saitoh Y; Bureta C; Sasaki H; Nagano S; Maeda S; Furukawa T; Taniguchi N; Setoguchi T
Mol Carcinog; 2019 Feb; 58(2):234-246. PubMed ID: 30303565
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing.
Zheng B; Qu Y; Wang J; Shi Y; Yan W
Cancer Genomics Proteomics; 2019; 16(3):221-228. PubMed ID: 31018952
[TBL] [Abstract][Full Text] [Related]
8. Mandibular undifferentiated pleomorphic sarcoma: Molecular analysis of a primary cell population.
Amm HM; DeVilliers P; Srivastava AR; Diniz MG; Siegal GP; MacDougall M
Clin Exp Dent Res; 2020 Oct; 6(5):495-505. PubMed ID: 32652895
[TBL] [Abstract][Full Text] [Related]
9. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
10. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
[TBL] [Abstract][Full Text] [Related]
12. Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein.
Oshiro H; Kiyuna T; Tome Y; Miyake K; Kawaguchi K; Higuchi T; Miyake M; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Nelson SD; Li Y; Bouvet M; Singh SR; Kanaya F; Hoffman RM
Anticancer Res; 2019 Jan; 39(1):81-85. PubMed ID: 30591443
[TBL] [Abstract][Full Text] [Related]
13. Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy.
Taborska P; Lukac P; Stakheev D; Rajsiglova L; Kalkusova K; Strnadova K; Lacina L; Dvorankova B; Novotny J; Kolar M; Vrana M; Cechova H; Ransdorfova S; Valerianova M; Smetana K; Vannucci L; Smrz D
Sci Rep; 2023 Nov; 13(1):19079. PubMed ID: 37925511
[TBL] [Abstract][Full Text] [Related]
14. The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Hildebrand KM; Singla AK; McNeil R; Marritt KL; Hildebrand KN; Zemp F; Rajwani J; Itani D; Bose P; Mahoney DJ; Jirik FR; Monument MJ
PLoS One; 2021; 16(7):e0253864. PubMed ID: 34242269
[TBL] [Abstract][Full Text] [Related]
15. YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma.
Rivera-Reyes A; Ye S; E Marino G; Egolf S; E Ciotti G; Chor S; Liu Y; Posimo JM; Park PMC; Pak K; Babichev Y; Sostre-Colón J; Tameire F; Leli NM; Koumenis C; C Brady D; Mancuso A; Weber K; Gladdy R; Qi J; Eisinger-Mathason TSK
Cell Death Dis; 2018 Oct; 9(11):1108. PubMed ID: 30382078
[TBL] [Abstract][Full Text] [Related]
16. Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma.
Fuller AM; DeVine A; Murazzi I; Mason NJ; Weber K; Eisinger-Mathason TSK
Cell Oncol (Dordr); 2022 Dec; 45(6):1277-1295. PubMed ID: 36181640
[TBL] [Abstract][Full Text] [Related]
17. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
Thway K; Fisher C
Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Fusion Transcripts in Undifferentiated Pleomorphic Sarcomas by Transcriptome Sequencing.
Zheng B; Zhang S; Cai W; Wang J; Wang T; Tang N; Shi Y; Luo X; Yan W
Cancer Genomics Proteomics; 2019; 16(5):399-408. PubMed ID: 31467233
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2.
Hakozaki M; Hojo H; Sato M; Tajino T; Yamada H; Kikuchi S; Abe M
Anticancer Res; 2006; 26(5A):3393-401. PubMed ID: 17094458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
